Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma
Nov 8, 2024
48:07
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
In this episode, Bernie and Anthony are joined by two special guest expert hematologists:
Dr. David Russler-Germain
Dr. Tycel Phillips
We discuss recent updates in the treatment of upfront Classical Hodgkin Lymphoma, including whether the SWOG S1826 and HD21 trials change practice! Will it be a landslide victory for nivolumab? Is brentuximab fired?
WolverHeme Happy Hour